This encompasses a large number of patients with metabolic syndrome, obesity, type 2 diabetes, chronic kidney disease, and familial hyperbetalipoproteinemia
Conclusion: The metabolic syndrome includes some reversible indicators such as overweight, hyperbetalipoproteinemia, hypertriglyceridemia, dyslipidemia, impaired fasting glucose, impaired glucose tolerance, and white coat hypertension for the development of terminal diseases including obesity, hypertension, diabetes mellitus, peripheral artery disease, coronary heart disease, and stroke.
For example in a previoud study16, prevalences of hyperbetalipoproteinemia, hypertriglyceridemia, dyslipidemia, impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and WCH showed a parallel fashion to excess weight by increasing until the seventh decade of life and decreasing afterwards (p less than 0.
So it actually contains the overweight, white coat hypertension (WCH), impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), hypertriglyceridemia, hyperbetalipoproteinemia, and dyslipidemia like risk factors for development of irreversible final diseases such as obesity, HT, DM, CHD, and stroke that decrease duration and/ or quality of life.
For example in a previous study12, prevalences of hypertriglyceridemia, hyperbetalipoproteinemia, dyslipidemia, IGT, and WCH showed a parallel trend to excess weight by increasing until the seventh decade and decreasing afterwards, significantly (p less than 0.